Pharmatrin Limited
Pharmatrin is developing a novel class of therapeutics known as indane dimers. The target therapeutic areas are organ transplant rejection and autoimmune diseases. The Company is based in Trinity College Dublin. Other investors include Catalyst Biomedica, Trinity Venture Capital, Enterprise Ireland and TCD.